Showing results 1 to 2 of 2
| Title | Author(s) | Issue Date | |
|---|---|---|---|
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis Journal:Journal of Hepatology | 2022 | ||
ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH Proceeding/Conference:Journal of Hepatology | 2021 |